Literature DB >> 3160983

Cesarean section or vaginal delivery at 24 to 28 weeks' gestation: comparison of survival and neonatal and two-year morbidity.

W Kitchen, G W Ford, L W Doyle, A L Rickards, J V Lissenden, R J Pepperell, J E Duke.   

Abstract

A large cohort of consecutive live births with gestational ages assessed antenatally from 24 to 28 weeks from one tertiary center was studied to determine the association between mode of delivery and in-hospital mortality and morbidity and morbidity at two years of age. Between 1 January 1977 and 31 March 1982, 52.8% (172 of 326) of such infants survived their primary hospitalization. Obstetric factors independently associated with improved survival were increasing gestational age (P less than .0001), the absence of maternal hypertension (P = .007), singleton pregnancy (P = .007), and antenatal steroid therapy (P = .018). Although 62.7% (32 of 51) of infants delivered by cesarean section survived compared with 50.9% (140 of 275) of infants delivered vaginally, the increased survival was not statistically significant (X 2 = 1.97). Moreover, the trend favoring cesarean section disappeared after adjustment for confounding obstetric factors. In univariate analyses cesarean births more frequently required ventilatory support and there was a trend toward a lower incidence of cerebroventricular hemorrhage; again, however, when adjusted for extraneous factors these associations disappeared. Of the 172 in-hospital survivors, five died at home unexpectedly; 162 of the remaining 167 were traced; 18 (11.1%) had cerebral palsy and two (1.2%) were deaf. Of the 111 children who were fully assessed, 13.5% had major handicaps, 23.4% were suspect, and 63.1% were free of handicap at two years' corrected age. There was no association between mode of delivery and frequency of handicap. Little evidence was found from mortality or morbidity data to support routine delivery of infants of borderline viability by cesarean section.

Entities:  

Mesh:

Year:  1985        PMID: 3160983

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

Review 1.  Fetal monitoring and neonatal resuscitation: what the anaesthetist should know.

Authors:  J Guay
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 2.  Perinatal management at the lower margin of viability.

Authors:  J M Rennie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

3.  Prognosis for infants born at 23 to 28 weeks' gestation.

Authors:  L W Doyle; W H Kitchen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

4.  Pregnancy outcome at 24-31 weeks' gestation: mortality.

Authors:  U Wariyar; S Richmond; E Hey
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

Review 5.  Evidence of selection bias in preterm survival studies: a systematic review.

Authors:  D J Evans; M I Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

6.  Perinatal factors and adverse outcome in extremely low birthweight infants.

Authors:  V Y Yu; L Downe; J Astbury; B Bajuk
Journal:  Arch Dis Child       Date:  1986-06       Impact factor: 3.791

7.  Effect of cesarean section on outcome in high- and low-risk very preterm infants.

Authors:  J Dietl; H Arnold; H Mentzel; H A Hirsch
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

8.  [Fetal death and complications in premature infants today].

Authors:  R Roos; C Bösche; O Genzel-Boroviczény; R Knitza; H Versmold; H Hepp
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 9.  [Characteristics of delivery of the small premature infant].

Authors:  H Schneider; E Berger-Menz; W Hänggi
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

10.  Delivery of very premature infants: does the caesarean section rate relate to mortality, morbidity, or long-term outcome?

Authors:  J Dietl; H Arnold; G Haas; H Mentzel; B Pietsch-Breitfeld; H A Hirsch
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.